Comparison of two techniques of pterygium surgery: graft from pterygium tissue versus free conjunctival graft

Comparison of two techniques of pterygium surgery, Rotational autograft from pterygium tissue versus free conjunctival graft in patients suufering from pterigyum: a clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016092119581N2

Enrollment

Registered

2017-11-04

Start date

2014-01-13

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pterygium. Pterygium

Interventions

Intervention 1: Intervention group: Pterygium surgery by using pteygium as transplanted tissue. In this method after pterygium removal, the fibrovascular tssue was removed from the pterygium and wi

Treatment - Surgery

Intervention group: Pterygium surgery by using pteygium as transplanted tissue. In this method after pterygium removal, the fibrovascular tssue was removed from the pterygium and with 180 degree

control group: pterygium surgery with free graft, In this method, after the removal of the pterygium, the supra temporal conjunctiva was used as graft. the patients were followed for 6 months.

Eligibility

Sex/Gender

All

Age

19 Years to 55 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria were: the presence of primary pterygium (temporal or nasal), having surgical indications (vision deterioration as a result of the involvement of visual axis and inducing irregular astigmatism, chronic eye irritation, recrudescent inflammation, limitation of eye movement, cosmetic problems, and more than 2 mm growth on the cornea), and the patient who were younger than 55. Primary pterygium is defined as having no history of pterygium surgery for the target eye. Exclusion criteria: the pterygiums being suspicious of conjunctival intraepithelial neoplasia; the presence of symblepharon; recrudescent pterygiums; double head pterygium; pseudopterygia; having a history of eye trauma and corneal scar.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Recurrence. Timepoint: 6 Months after the intervention. Method of measurement: Slit lamp.	—

Secondary

Measure	Time frame
Graft injection. Timepoint: 6 Months after the intervention. Method of measurement: with slit lamp.;Cosmesis. Timepoint: 6 Months after the intervention. Method of measurement: with slit lamp.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDoctor Shahram Bamdad

Shiraz University of Medical Sciences

Shahrambamdad@yahoo.com+98 71 3230 5410

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 8, 2026